RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.

Author: KalinkaEwa, KowalskiDariusz M, KrawczykPaweł, KubiatowskiTomasz, KucharczykTomasz, PłużańskiAdam

Paper Details 
Original Abstract of the Article :
Mutations and fusions of <i>RET</i> (rearranged during transfection) gene are detected in a few common types of tumors including thyroid or non-small cells lung cancers. Multiple kinase inhibitors (MKIs) do not show spectacular effectiveness in patients with <i>RET</i>-altered tumors. Hence, recentl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657474/

データ提供:米国国立医学図書館(NLM)

RET Proto-Oncogene: A Complex Target in Cancer Therapy

The [treatment of cancers with RET gene alterations] is an ongoing area of research in [oncology]. This review discusses the [molecular mechanisms] involved in [RET gene alterations] and the challenges associated with developing targeted therapies. The authors highlight the importance of [understanding the function of the normal RET receptor] and the [types of molecular disturbances] that can occur in the RET gene. They also discuss the [efficacy of various anticancer therapies], including [kinase inhibitors (MKIs)] and [RET-specific inhibitors]. The review underscores the complexity of targeting the RET gene and the need for further research to develop more effective and durable treatments.

Emerging Strategies for Targeting RET Gene Alterations in Cancer

This review provides a comprehensive overview of the [molecular complexities] associated with [RET gene alterations] in cancer. The authors discuss the [challenges and opportunities] presented by this target and highlight the emergence of [RET-specific inhibitors] as promising therapeutic options. However, the review also emphasizes the need for [continued research] to overcome the challenges of resistance and optimize treatment strategies.

New Hope for Cancer Patients with RET Gene Alterations

This review offers a hopeful glimpse into the future of [cancer treatment] for patients with [RET gene alterations]. The development of [RET-specific inhibitors] represents a significant advancement in targeted therapies. However, it’s important to recognize that [ongoing research] is crucial for addressing the challenges of resistance and ensuring the long-term effectiveness of these treatments.

Dr.Camel's Conclusion

Just as the camel navigates the vast and often unforgiving desert, the journey of treating cancer is long and complex. This review helps us understand the intricacies of RET gene alterations and the emerging strategies for targeting them. The development of RET-specific inhibitors offers a beacon of hope, paving the way for a brighter future for patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-11-17
Further Info :

Pubmed ID

36358717

DOI: Digital Object Identifier

PMC9657474

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.